-
China updates COVID-19 diagnosis, treatment protocol
2023-01-10
Introducing a set of revisions, health authorities on Friday released the 10th edition of the country's COVID-19 treatment plan, which guides hospitals nationwide as Omicron-fueled outbreaks keep progression across the nation.
-
First domestic ECMO machine to play vital role
2023-01-10
The official launch of the first domestically developed extracorporeal membrane oxygenation machine will play an important role in helping treat COVID-19 patients in critical condition and boosting the development of the country's high-end medical devices.
-
China's latest COVID-19 control protocol highlights vaccination, personal protection
2023-01-10
China released its 10th edition of COVID-19 control protocol on Saturday, highlighting vaccination and personal protection.
-
COVID treatment Molnupiravir approved for import in China
2023-01-04
China's top drug regulator said on Friday that it has granted conditional market approval for the import of Merck's COVID-19 treatment, Molnupiravir.
-
Mr Xu Jinghe Attends the “CIMDR - GHWP Session & International Drug Regulatory Authorities Dialogue”
2022-12-28
On the evening of December 20, 2022, the "China International Medical Device Regulatory Forum (CIMDR) - Global Harmonization Working Party (GHWP) Session & International Drug Regulatory Authorities Dialogue" was held online. Mr Xu Jinghe, Deputy Commissioner of the National Medical Products Administration (NMPA), attended the meeting online and delivered keynote speech.
-
China has 13 COVID vaccines available for second booster
2022-12-27
A total of 13 types of COVID-19 vaccines, approved for conditional marketing or emergency use, are now available as a second booster dose in China, according to experts with the State Council inter-agency task force for COVID-19 response.
